Funding for this research was provided by:
U.S. President’s Emergency Plan for AIDS Relief (N/A)
National Institute of Allergy and Infectious Diseases (AI50440)
Canadian Institutes of Health Research (HCT 44180)
Received: 14 February 2018
Accepted: 17 July 2018
First Online: 28 July 2018
Ethics approval and consent to participate
: This secondary analysis obtained IRB approval from the Kenyatta National Hospital ethics and research committee, and exemption determinations from CDC Human Subjects Review and a University of Illinois IRB.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.